35
https://pubmed.ncbi.nlm.nih.gov/38115347
A patient with refractory mixed phenotype acute leukemia achieved complete remission after treatment with human CD19-targeted CAR-T cell therapy, highlighting the potential of this approach for managing this challenging disease.